Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Combinatorial Chemistry & High Throughput Screening|January 8, 2010
Enzyme induction: translating multiple approaches, assays, endpoints, and opinions into a valuable induction screening strategyAdrian Fretland, Mario MonshouwerToxicology in Vitro : an International Journal Published in Association with BIBRA|November 6, 2003
Hepatic (dys-)function during inflammationMario Monshouwer, Kasper H N HoebePharmaceutical Research|October 19, 2006
Analytical tools and approaches for metabolite identification in early drug discoveryYuan Chen, Mario Monshouwer, William L FitchDrug Metabolism and Disposition: the Biological Fate of Chemicals|August 13, 2011
Determination of time-dependent inactivation of CYP3A4 in cryopreserved human hepatocytes and assessment of human drug-drug interactionsYuan Chen, Liling Liu, Mario Monshouwer, et al.Toxicology|May 6, 2004
A human and mouse pregnane X receptor reporter gene assay in combination with cytotoxicity measurements as a tool to evaluate species-specific CYP3A inductionLuisella A Vignati, Alessia Bogni, Pietro Grossi, et al.Clinical Pharmacokinetics|November 30, 2016
Elucidating the Plasma and Liver Pharmacokinetics of Simeprevir in Special Populations Using Physiologically Based Pharmacokinetic ModellingJan Snoeys, Maria Beumont, Mario Monshouwer, et al.BMC Cancer|January 6, 2021
EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development and barrier functionNicolas Joly-Tonetti, Thomas Ondet, Mario Monshouwer, et al.JID Innovations : Skin Science From Molecules to Population Health|December 15, 2021
Unlocking the Mechanisms of Cutaneous Adverse Drug Reactions: Activation of the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway by EGFR Inhibitors Triggers Keratinocyte Differentiation and Polarization of Epidermal Immune ResponsesThomas Ondet, Pierre-François Roux, Mario Monshouwer, et al.Clinical Pharmacokinetics|April 18, 2018
Clinical Investigation of Coproporphyrins as Sensitive Biomarkers to Predict Mild to Strong OATP1B-Mediated Drug-Drug InteractionsAnnett Kunze, Emmanuel Njumbe Ediage, Lieve Dillen, et al.Cancer Chemotherapy and Pharmacology|December 14, 2004
Lack of strain-related differences in drug metabolism and efflux transporter characteristics between CD-1 and athymic nude miceMarcella Martignoni, Ruben de Kanter, Anna Moscone, et al.Pageof 5